Literature DB >> 26697770

Evaluating and mitigating fracture risk in established rheumatoid arthritis.

Matthew B Mullen1, Kenneth G Saag2.   

Abstract

Patients with rheumatoid arthritis are predisposed to systemic bone loss, and they are at an increased risk of fractures. Although there are similarities in the patient demographics between rheumatoid arthritis patients and the general population of osteoporosis patients, there are factors, particularly the use of glucocorticoids, which are specific to rheumatoid arthritis. These factors can lead to an increased risk of bone loss and fracture. Given that fractures are often very debilitating, especially in elderly patients, it is of paramount importance for the practicing rheumatologist to be aware of ways to reduce the risk of fracture in patients with rheumatoid arthritis. This review discusses currently available modalities for fracture risk assessment as well as pharmacologic and lifestyle interventions available to treat and prevent bone loss in rheumatoid arthritis patients.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fracture risk; Glucocorticoid-induced osteoporosis; Osteoporosis; Rheumatoid arthritis

Mesh:

Substances:

Year:  2015        PMID: 26697770     DOI: 10.1016/j.berh.2015.09.005

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  7 in total

1.  The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study.

Authors:  Alexis Ogdie; Lauren Harter; Daniel Shin; Joshua Baker; Junko Takeshita; Hyon K Choi; Thorvardur Jon Love; Joel M Gelfand
Journal:  Ann Rheum Dis       Date:  2017-01-16       Impact factor: 19.103

2.  Incidence of fractures among patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  S Jin; E Hsieh; L Peng; C Yu; Y Wang; C Wu; Q Wang; M Li; X Zeng
Journal:  Osteoporos Int       Date:  2018-03-15       Impact factor: 4.507

3.  Relationship between PI3K pathway and angiogenesis in CIA rat synovium.

Authors:  Lin Zou; Guichun Zhang; Lifeng Liu; Chen Chen; Xuecheng Cao; Jinfang Cai
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

4.  Micro-structural bone changes in early rheumatoid arthritis persist over 1-year despite use of disease modifying anti-rheumatic drug therapy.

Authors:  Lynne M Feehan; Linda L Li; Heather A McKay
Journal:  BMC Musculoskelet Disord       Date:  2017-12-11       Impact factor: 2.362

5.  Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis.

Authors:  Ji-Heh Park; Eun-Kyoung Park; Dong-Wan Koo; Shinwon Lee; Sun-Hee Lee; Geun-Tae Kim; Seung-Geun Lee
Journal:  BMC Musculoskelet Disord       Date:  2017-04-11       Impact factor: 2.362

Review 6.  Polyunsaturated fatty acids: any role in rheumatoid arthritis?

Authors:  Luca Navarini; Antonella Afeltra; Gabriele Gallo Afflitto; Domenico Paolo Emanuele Margiotta
Journal:  Lipids Health Dis       Date:  2017-10-10       Impact factor: 3.876

7.  Bone fracture risk in patients with rheumatoid arthritis: A meta-analysis.

Authors:  A-Li Xue; Su-Ye Wu; Lei Jiang; Ai-Mei Feng; Hai-Fei Guo; Pu Zhao
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.